AzTrials
AzTrials

Parkinson DiseaseNCT05958355

Effects of Functional Postural Control Training on Functional Performance in People With Parkinson's Disease With Freezing of Gait

A study testing Treadmill training in people with Parkinson Disease, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this single-blinded, randomized controlled study aims to establish the effects of functional postural control training on functional performance and FOG in PD individuals with FoG as compared with treadmill training. Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Parkinson Disease
What is being tested?
Treadmill training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteTaiwan
Study dates
1 Aug 2023to Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Hoehn and Yahr stage 2~4
  • Age between 50 to 80 years
  • New Freezing of Gait Questionnaire score > 1
  • Able to walk independently for at least 10 meters
  • MMSE score ≥24

Who cannot join

  • Neurological diseases other than PD
  • Any cardiovascular, pulmonary, or orthopedic conditions that would impact participation in the study

Trial locations and contacts

1 site in 1 country.

Ray-Yau Wang, PhD contact

+886-2-2826-7210

rywang@nycu.edu.tw

Taiwan1 site
  • National Yang Ming Chiao Tung University

    Taipei, 112

Other trials in Taiwan

About this study

The purpose of this single-blinded, randomized controlled study aims to establish the effects of functional postural control training on functional performance and FOG in PD individuals with FoG as compared with treadmill training.

Read the detailed description

Background and purpose: Freezing of gait (FoG), is a common sign in patients with Parkinson's disease (PD), especially at the advanced stage. Advanced functional activities, such as dual task walking, turning, or crossing a door often induce the FOG. FoG is a complex phenomenon which pathophysiology is currently unknown. However, previous studies have found that postural instability may be a risk factor for FoG. In addition, previous studies have suggested the interactions between FoG and postural instability. Treadmill training has been shown to be relatively more effective to improve FoG than other interventions. On the other hand, postural control training was demonstrated to improve the severity of FoG and postural control in freezers. However, no study has investigated the effectiveness of functional postural control training on functional performance and FOG. Therefore, this study aims to establish the effects of functional postural control training on functional performance and FOG in PD individuals with FoG as compared with treadmill training.

Methods: This study is a single-blinded randomized controlled trial. Twenty PD people with FoG will be recruited and randomized to the experimental and control group. The experimental group will receive functional postural control training, and the control group will receive treadmill training. Each intervention is 30 minutes/ session, 3 sessions/ weeks, for 4 weeks. The primary outcome is functional performance, which will measure the walking speed, cadence, and step length in the four conditions, including (1) Time up and go test, (2) Dual task Time up and go test, (3) 360º turning in place, and (4) Walking through the door. The secondary outcome is the severity of FoG which is assessed by the New Freezing of Gait Questionnaire (NFOGQ). All outcomes will be assessed before and after the training program. Demographic data at baseline will be analyzed by using Chi-square test or independent T-test. Two-way repeated ANOVA will be performed to analyze the primary and secondary outcomes. The significance level is set at p<0.05.

Being tested
Functional postural control training, Treadmill training
Keywords
Freezing of gait, Functional postural control training, Functional performance, Parkinson's disease
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional postural control trainingOther

    All participants will receive functional postural control training for 30 minutes/ session, 3 sessions/ weeks, for 4 weeks (a total of 12 training sessions).

  • Treadmill trainingOther

    All participants will receive treadmill training for 30 minutes/ session, 3 sessions/ weeks, for 4 weeks (a total of 12 training sessions).

Study groups in NCT05958355
Study groupRoleWhat they receive
Functional postural control trainingExperimentalThe training includes (1) Maintaining a stationary posture in a standing position for a total of 10 minutes, (2) Posture control training involving unilateral lower limb stepping movements for a total of 10 minutes, and (3) Advanced walking task training, including sudden stops, turns, ball raises, and obstacle crossing during walking, for a total of 10 minutes.
Receives: Other: Functional postural control training
Treadmill trainingActive comparatorThe subjects in the control group performed a 30-minute walking session on a treadmill at a self-selected speed.
Receives: Other: Treadmill training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional performance-Time up and go test-speed(m/s)

    Using GaitUp system to evaluate walking speed during the Time Up and Go test.

    Measured: Change from baseline time up and go test walking speed and up to 4 weeks (pre- and post-test)

  2. Functional performance-Time up and go test-cadence (steps/ min)

    Using GaitUp system to evaluate cadence during the Time Up and Go test.

    Measured: Change from baseline time up and go test cadence and up to 4 weeks (pre- and post-test)

  3. Functional performance-Time up and go test-step length (m)

    Using GaitUp system to evaluate step length during the Time Up and Go test.

    Measured: Change from baseline time up and go test step length and up to 4 weeks (pre- and post-test)

  4. Functional performance-dual task Time up and go test-speed(m/s)

    Using GaitUp system to evaluate walking speed during the dual task Time up and go test.

    Measured: Change from baseline dual task time up and go test walking speed and up to 4 weeks (pre- and post-test)

  5. Functional performance-dual task Time up and go test-cadence (steps/ min)

    Using GaitUp system to evaluate cadence during the dual task Time up and go test.

    Measured: Change from baseline dual task time up and go test cadence and up to 4 weeks (pre- and post-test)

  6. Functional performance-dual task Time up and go test-step length (m)

    Using GaitUp system to evaluate step length during the dual task Time up and go test.

    Measured: Change from baseline dual task time up and go test step length and up to 4 weeks (pre- and post-test)

  7. Functional performance-360º turning in place-speed(m/s)

    Using GaitUp system to evaluate speed during the 360º turning in place test.

    Measured: Change from baseline 360º turning in place speed and up to 4 weeks (pre- and post-test)

  8. Functional performance-360º turning in place-cadence (steps/ min)

    Using GaitUp system to evaluate cadence during the 360º turning in place test.

    Measured: Change from baseline 360º turning in place cadence and up to 4 weeks (pre- and post-test)

  9. Functional performance-360º turning in place-step length (m)

    Using GaitUp system to evaluate step length during the 360º turning in place test.

    Measured: Change from baseline 360º turning in place step length and up to 4 weeks (pre- and post-test)

  10. Functional performance-Walking through the door-speed(m/s)

    Using GAITRite® system to evaluate walking speed during walks through the door.

    Measured: Change from baseline walking through the door speed and up to 4 weeks (pre- and post-test)

  11. Functional performance-Walking through the door-cadence (steps/ min)

    Using GAITRite® system to evaluate cadence during walks through the door.

    Measured: Change from baseline walking through the door cadence and up to 4 weeks (pre- and post-test)

  12. Functional performance-Walking through the door-step length (m)

    Using GAITRite® system to evaluate step length during walks through the door.

    Measured: Change from baseline walking through the door step length and up to 4 weeks (pre- and post-test)

Secondary outcomes (1)
  1. New Freezing of Gait Questionnaire (NFOGQ)

    Use the New Freezing of Gait Questionnaire (NFOGQ)-Chinese version to assess the severity of freezing of gait.

    The score ranged from 0 to 29. Higher scores show increased severity in freezing of gait.

    Measured: Change from baseline New Freezing of Gait Questionnaire and up to 4 weeks (pre- and post-test)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2023
  2. Study start1 Aug 2023 (estimated)
  3. Primary completionJun 2024 (estimated)
  4. Study completionJun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05958355
Sponsor's protocol ID
NYCU112071AF
Status last verified
Jul 2023
First submitted
14 Jul 2023
Last updated
28 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Treadmill training in people with Parkinson Disease, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ray-Yau Wang, PhD (+886-2-2826-7210, rywang@nycu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional performance-Time up and go test-speed(m/s) (time frame: Change from baseline time up and go test walking speed and up to 4 weeks (pre- and post-test)). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in